COMPLETED

An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)

Conditions

Depressive Symptoms Coronary Heart Disease Implementation science

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.

Official Title

An Information tecHnology Approach to implEmenting Depression treAtment in caRdiac patienTs: [iHeartDepCare Trial]

Quick Facts

Study Start:2019-04-23

Study Completion:2025-04-10

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT03882411

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* History of coronary heart disease * English or Spanish Speaking * Elevated Depressive symptoms (PHQ9 ≥10) * Appointment at participating cardiology or primary care clinics	* Under the care of a psychiatrist \[\\On 6/22/2022, this exclusion criteria was removed for those clusters of clinics not already in the post-implementation period\\\] * Diagnosis/history of psychosis or schizophrenia * Diagnosis/history of bipolar disorder * Attempted suicide * Non-English or Spanish speaking * Dementia or severe cognitive impairment * Non-elevated depressive symptoms * Alcohol or substance abuse * Pregnancy

Inclusion Criteria

Exclusion Criteria

* History of coronary heart disease
* English or Spanish Speaking
* Elevated Depressive symptoms (PHQ9 ≥10)
* Appointment at participating cardiology or primary care clinics

* Under the care of a psychiatrist \[\*\*On 6/22/2022, this exclusion criteria was removed for those clusters of clinics not already in the post-implementation period\*\*\]
* Diagnosis/history of psychosis or schizophrenia
* Diagnosis/history of bipolar disorder
* Attempted suicide
* Non-English or Spanish speaking
* Dementia or severe cognitive impairment
* Non-elevated depressive symptoms
* Alcohol or substance abuse
* Pregnancy

Contacts and Locations

Principal Investigator

Nathalie Moise, MD, MS

PRINCIPAL_INVESTIGATOR

Columbia University

Study Locations (Sites)

Columbia University Irving Medical Center/New York Presbyterian Hospital

New York, New York, 10032

United States

Collaborators and Investigators

Sponsor: Columbia University

Nathalie Moise, MD, MS, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-04-23

Study Completion Date2025-04-10

Study Record Updates

Study Start Date2019-04-23

Study Completion Date2025-04-10

Terms related to this study

Keywords Provided by Researchers

Implementation science

Additional Relevant MeSH Terms

Depressive Symptoms
Coronary Heart Disease